ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNSE Sensei Biotherapeutics Inc

0.7799
0.0249 (3.30%)
Jun 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 212,564
Bid Price 0.61
Ask Price 1.30
News -
Day High 0.8199

Low
0.51

52 Week Range

High
1.94

Day Low 0.72
Company Name Stock Ticker Symbol Market Type
Sensei Biotherapeutics Inc SNSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0249 3.30% 0.7799 00:00:11
Open Price Low Price High Price Close Price Prev Close
0.7323 0.72 0.8199 0.7396 0.755
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
466 212,564 $ 0.7532139 $ 160,106 - 0.51 - 1.94
Last Trade Time Type Quantity Stock Price Currency
19:55:10 7 $ 0.7799 USD

Sensei Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
19.05M 25.07M - 0 -34.1M -1.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sensei Biotherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SNSE Message Board. Create One! See More Posts on SNSE Message Board See More Message Board Posts

Historical SNSE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.890.890.68760.800325645,005-0.1101-12.37%
1 Month1.761.940.68761.31360,457-0.9801-55.69%
3 Months0.971.940.68761.35254,739-0.1901-19.60%
6 Months0.67291.940.597751.23148,2290.10715.90%
1 Year1.481.940.511.1691,791-0.7001-47.30%
3 Years12.4713.000.513.4485,645-11.69-93.75%
5 Years24.7026.380.516.1598,066-23.92-96.84%

Sensei Biotherapeutics Description

Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response.

Your Recent History

Delayed Upgrade Clock